Granules India Limited (GRANULES) Share Price & AI Investment Analysis

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally. It offers paracetamol, metformin, guaifenesin, ibuprofen, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. Track Granules India Limited's live NSE:GRANULES share price ₹864.05 (-1.23%), market cap ₹₹236B, P/E 32.1. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for GRANULES — real-time NSE India stock intelligence.